Drug Profile
WCK 5153
Alternative Names: WCK-5153Latest Information Update: 04 Sep 2023
Price :
$50
*
At a glance
- Originator Wockhardt
- Class Antibacterials; Azabicyclo compounds; Small molecules
- Mechanism of Action Penicillin-binding protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 04 Sep 2023 Discontinued - Preclinical for Bacterial infections in USA (IV) (Wockhardt pipeline, September 2023)
- 28 May 2020 No recent reports of development identified for preclinical development in Bacterial-infections in USA (IV)
- 22 Apr 2017 Pharmacodynamics data from a preclinical trial in Bacterial infections presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID-2017)